Inflammatory Demyelinating Polyneuropathy
📧 Sign up to get email alerts when something new happens for Inflammatory Demyelinating Polyneuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP [Phase 3]
An ongoing Phase 3 long-term safety and efficacy study of riliprubart in participants with chronic inflammatory demyelinating polyneuropathy…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Phase 3]
A Phase 3 clinical trial investigating the efficacy and safety of Riliprubart versus the usual IVIg treatment in chronic inflammatory demyel…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE) [Phase 3]
A Phase 3 clinical trial (CAPTIVATE) evaluating the efficacy and safety of DNTH103 in adults with chronic inflammatory demyelinating polyneu…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases [Phase 1]
A Phase 1 trial evaluating the safety and preliminary efficacy of KITE-363 in relapsed/refractory autoimmune neurologic diseases is currentl…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP [Phase 3]
A Phase 3 study to assess the efficacy and safety of Empasiprubart versus IVIg in adults with CIDP is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy [Phase 3]
A Phase 3 study is evaluating the pharmacokinetics and safety of XEMBIFY versus Gamunex-C in participants with CIDP; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Safety, Tolerability, and Efficacy of NVG-2089 in Participants With CIDP [Phase 2]
A Phase 2 clinical trial assessing the safety, tolerability, and efficacy of NVG-2089 in participants with chronic inflammatory demyelinatin…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Phase 3]
A Phase 3 trial evaluating intravenous immunoglobulin (IGIV) 10% for chronic inflammatory demyelinating polyneuropathy is currently recruiti…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Phase 2, Phase 3]
A Phase 2/3 clinical trial investigating Nipocalimab for adults with chronic inflammatory demyelinating polyneuropathy (CIDP) is currently r…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases. [Phase 1]
Phase 1 clinical trial update assessing the safety and pharmacodynamics of QH103 cell injections in relapsed/refractory antibody-mediated ne…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work [Phase 3]
Phase 3 clinical trial evaluating the effects and safety of Riliprubart for chronic inflammatory demyelinating polyneuropathy that does not …
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Empasiprubart in adults with chronic inflammatory demyelinating polyneuropathy (CIDP) is…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Subcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart Devices
A clinical trial evaluating subcutaneous immunoglobulin therapy for Chronic Inflammatory Demyelinating Polyneuropathy with effectiveness mon…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Studying Nerve Function and Structure in Charcot-Marie-Tooth Disease, Anti-MAG Neuropathy and CIDP
This clinical trial update indicates ongoing recruitment for a study evaluating nerve function and structure in Charcot-Marie-Tooth disease …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases [Phase 2]
Phase 2 clinical trial investigating autologous stem cell transplant for neurologic autoimmune diseases is currently active but not recruiti…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
A worldwide pregnancy safety study is recruiting to assess maternal, fetal, and infant outcomes after exposure to efgartigimod during pregna…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases [EARLY_Phase 1]
An early-phase UCAR-T therapy targeting CD19/BCMA is being evaluated for relapsing or refractory multiple sclerosis, myasthenia gravis, CIDP…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Phase 2]
Open-label extension study of Batoclimab in adults with chronic inflammatory demyelinating polyneuropathy (CIDP) is currently enrolling by i…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases [EARLY_Phase 1]
A Phase 1 trial evaluating a universal CAR T-cell therapy targeting CD19 and BCMA in relapsed/refractory neurological autoimmune diseases, w…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: IVIG vs SCIG in CIDP [Phase 1]
A Phase 1 clinical trial comparing intravenous immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG) for chronic inflammatory demyeli…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Our Study Aims to Determine if Nerve Alterations in Acute GBS and CIDP Detectable by Ultrasound Match Electrodiagnostic Findings and if This Method Aids Early Diagnosis, Predict Their Outcomes and Differentiate Between Axonal and Demyelinating Subtypes.
This clinical trial aims to determine if ultrasound-detected nerve alterations in acute Guillain-Barré syndrome and chronic inflammatory dem…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: An Expanded Access IND for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
This clinical trials update discusses an Expanded Access IND for Chronic Inflammatory Demyelinating Polyneuropathy. The status indicates the…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
This study investigates immunoadsorption as a treatment for chronic inflammatory demyelinating polyneuropathy and is currently recruiting, s…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy
This clinical trial update describes evaluation of multispectral optoacoustic imaging to detect inflammation and damage in peripheral nerves…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)
Sanofi-sponsored real-world study evaluating treatment outcomes in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is currently rec…